当前位置:首页 - 行情中心 - 永顺生物(920729) - 财务分析 - 现金流量表

永顺生物

(920729)

  

流通市值:7.61亿  总市值:27.09亿
流通股本:7682.50万   总股本:2.73亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金199,825,102.97128,642,442.9862,543,452.77266,396,473.85
  收到其他与经营活动有关的现金3,579,364.952,419,988.4855,876.398,410,932.18
  经营活动现金流入小计203,404,467.92131,062,431.3863,399,329.16274,807,406.03
  购买商品、接受劳务支付的现金41,205,947.0127,943,282.613,546,120.8674,124,526.79
  支付给职工以及为职工支付的现金42,751,436.7730,290,976.7718,016,736.0857,058,704.77
  支付的各项税费8,651,592.287,035,510.613,864,993.4213,346,085.2
  支付其他与经营活动有关的现金36,133,852.8822,442,105.4310,909,025.157,741,447.31
  经营活动现金流出小计128,742,828.9487,711,875.4146,336,875.46202,270,764.07
  经营活动产生的现金流量净额74,661,638.9843,350,555.9717,062,453.772,536,641.96
二、投资活动产生的现金流量:
  收回投资收到的现金311,473,424.09227,812,633.19120,362,370.26346,207,991.85
  处置固定资产、无形资产和其他长期资产收回的现金净额---212,400
  投资活动现金流入小计311,473,424.09227,812,633.19120,362,370.26346,420,391.85
  购建固定资产、无形资产和其他长期资产支付的现金4,029,405.51,422,859.5170,557.5633,217.53
  投资支付的现金380,759,800.4273,159,800.4166,869,800.4496,417,572.85
  投资活动现金流出小计384,789,205.9274,582,659.9167,040,357.9497,050,790.38
  投资活动产生的现金流量净额-73,315,781.81-46,770,026.71-46,677,987.64-150,630,398.53
三、筹资活动产生的现金流量:
  取得借款收到的现金1,331,613.621,331,613.621,331,613.6227,380,732.2
  收到其他与筹资活动有关的现金14,182,80014,182,80014,182,8001,513,200
  筹资活动现金流入小计15,514,413.6215,514,413.6215,514,413.6228,893,932.2
  偿还债务支付的现金---25,693,166.82
  分配股利、利润或偿付利息支付的现金35,535,50035,535,500-49,145,065.48
  支付其他与筹资活动有关的现金474,034.86319,206.28154,603.14618,749.9
  筹资活动现金流出小计36,009,534.8635,854,706.28154,603.1475,456,982.2
  筹资活动产生的现金流量净额-20,495,121.24-20,340,292.6615,359,810.48-46,563,050
四、汇率变动对现金及现金等价物的影响31,809.41104,841.04133,736.22-44,808.91
五、现金及现金等价物净增加额-19,117,454.66-23,654,922.36-14,121,987.24-124,701,615.48
  加:期初现金及现金等价物余额36,440,574.1836,440,574.1836,440,574.18161,142,189.66
  期末现金及现金等价物余额17,323,119.5212,785,651.8222,318,586.9436,440,574.18
补充资料:
  净利润-19,720,898.19-40,143,422.44
  资产减值准备-1,283,852.91-3,191,563.71
  固定资产和投资性房地产折旧-15,170,877.45-30,484,086.93
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-15,170,877.45-30,484,086.93
  无形资产摊销-1,458,282-3,069,215.66
  长期待摊费用摊销-71,578.98-143,157.96
  固定资产报废损失-8,223.86--176,251.35
  公允价值变动损失--124,881.69--334,929.02
  财务费用--55,786.55-672,119.84
  投资损失--5,288,037.98--8,664,786.36
  递延所得税-137,785.13--435,877.58
  其中:递延所得税资产减少--249,787.32--339,323.34
    递延所得税负债增加-387,572.45--96,554.24
  存货的减少-670,613.89-7,882,385.26
  经营性应收项目的减少-6,300,526.17-14,898,497.74
  经营性应付项目的增加--668,575.4--19,210,675.1
  其他-4,343,939.52-490,645.16
  现金的期末余额-12,785,651.82-36,440,574.18
  减:现金的期初余额-36,440,574.18-161,142,189.66
  现金及现金等价物的净增加额--23,654,922.36--124,701,615.48
公告日期2025-10-282025-08-262025-04-282025-04-28
审计意见(境内)标准无保留意见
TOP↑